000			01968nam a22002537a 4500
003			ZW-GwMSU
005			20240817123155.0
008			240817b |||||||| |||| 00| 0 eng d
022			_a02198770
040			_aMSU _bEnglish _cMSU _erda
050	0	0	_aHD451.557
100	1		_aHasse, Raimund _eauthor
245	1	0	_aInstitutions, dominant actors, and financial markets : _bthe case of venture capital for biotechnology in Switzerland/ _ccreated by Raimund Hasse and Eva Passarge
264	1		_aNew Jersey : _bWorld Scientific Publishing, _c2016.
336			_2rdacontent _atext _btxt
337			_2rdamedia _aunmediated _bn
338			_2rdacarrier _avolume _bnc
440			_aWorld Scientific Publishing _vVolume 13, number 6
520	3		_aSince the 1990s, the new economic sociology has directed attention toward markets and, in particular, financial markets. Thus far, neo-institutional theory has not been able to make substantial contribution to this research front. We identify reasons for this shortcoming and aim to expand the scope of institutional analysis by focusing upon the constitution and governance of financial markets. Referring to the case of venture capital markets for biotechnology in Switzerland, it will be shown that the formation of the market has been strongly linked to the big Swiss pharmaceutical companies. Data are presented which indicate that the emerging venture capital market for biotechnology in Switzerland resembles contextual features such as collective arrangements and risk-averse investment strategies. The case illustrates that both the set-up of the market and its characteristic features are only loosely coupled to an abstract worldwide financial market, and, instead, are deeply interwoven with the national and sectoral context.
650			_aFinance _vFinancial markets _xEconomic sociology _zSwitzerland
700	1		_aPassarge, Eva _eco author
856			_uhttps://doi.org/10.1142/S0219877017500018
942			_2lcc _cJA
999			_c166739 _d166739